Cargando…

Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant

Detalles Bibliográficos
Autores principales: Zhang, Na-Na, Zhang, Rong-Rong, Zhang, Yi-Fei, Ji, Kai, Xiong, Xiao-Chuan, Qin, Qian-Shan, Gao, Peng, Lu, Xi-Shan, Zhou, Hang-Yu, Song, Hai-Feng, Ying, Bo, Qin, Cheng-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853430/
https://www.ncbi.nlm.nih.gov/pubmed/35165421
http://dx.doi.org/10.1038/s41422-022-00626-w
_version_ 1784653226238279680
author Zhang, Na-Na
Zhang, Rong-Rong
Zhang, Yi-Fei
Ji, Kai
Xiong, Xiao-Chuan
Qin, Qian-Shan
Gao, Peng
Lu, Xi-Shan
Zhou, Hang-Yu
Song, Hai-Feng
Ying, Bo
Qin, Cheng-Feng
author_facet Zhang, Na-Na
Zhang, Rong-Rong
Zhang, Yi-Fei
Ji, Kai
Xiong, Xiao-Chuan
Qin, Qian-Shan
Gao, Peng
Lu, Xi-Shan
Zhou, Hang-Yu
Song, Hai-Feng
Ying, Bo
Qin, Cheng-Feng
author_sort Zhang, Na-Na
collection PubMed
description
format Online
Article
Text
id pubmed-8853430
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-88534302022-02-18 Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant Zhang, Na-Na Zhang, Rong-Rong Zhang, Yi-Fei Ji, Kai Xiong, Xiao-Chuan Qin, Qian-Shan Gao, Peng Lu, Xi-Shan Zhou, Hang-Yu Song, Hai-Feng Ying, Bo Qin, Cheng-Feng Cell Res Letter to the Editor Springer Singapore 2022-02-14 2022-04 /pmc/articles/PMC8853430/ /pubmed/35165421 http://dx.doi.org/10.1038/s41422-022-00626-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editor
Zhang, Na-Na
Zhang, Rong-Rong
Zhang, Yi-Fei
Ji, Kai
Xiong, Xiao-Chuan
Qin, Qian-Shan
Gao, Peng
Lu, Xi-Shan
Zhou, Hang-Yu
Song, Hai-Feng
Ying, Bo
Qin, Cheng-Feng
Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
title Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
title_full Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
title_fullStr Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
title_full_unstemmed Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
title_short Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
title_sort rapid development of an updated mrna vaccine against the sars-cov-2 omicron variant
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853430/
https://www.ncbi.nlm.nih.gov/pubmed/35165421
http://dx.doi.org/10.1038/s41422-022-00626-w
work_keys_str_mv AT zhangnana rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant
AT zhangrongrong rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant
AT zhangyifei rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant
AT jikai rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant
AT xiongxiaochuan rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant
AT qinqianshan rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant
AT gaopeng rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant
AT luxishan rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant
AT zhouhangyu rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant
AT songhaifeng rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant
AT yingbo rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant
AT qinchengfeng rapiddevelopmentofanupdatedmrnavaccineagainstthesarscov2omicronvariant